Skip to the main content.
Login Contact us

1 min read

Arterys' Breast AI Suite: Transforming Breast Screening & Cancer Detection at SBI 2023

Arterys' Breast AI Suite: Transforming Breast Screening & Cancer Detection at SBI 2023

The 2023 Society of Breast Imaging (SBI) Breast Imaging Symposium is a must-attend event for radiologists and healthcare professionals involved in breast imaging. Scheduled from May 4th to 7th at the Gaylord National Resort & Convention Center in National Harbor, Maryland, the symposium focuses on the theme "Advancing What's Possible: Better Every Day." Arterys, A Tempus Company, is excited to be part of this year's event, showcasing our innovative Breast AI product at Booth #408.

Symposium Highlights

The SBI Breast Imaging Symposium will feature a variety of interactive and educational sessions, including a Shark Tank event where contestants pitch their vision for breast screening in 2030, keynote speakers, and the engaging Tumor Board. Additionally, there will be discussions on practice efficiency, emerging paradigms, and novel approaches to work. The symposium will also offer a sneak peek into the next edition of BI-RADS, case-based learning sessions, and more.

 

Arterys Breast AI: Revolutionizing Breast Cancer Detection

As a participant in this prestigious event, Arterys is proud to present our groundbreaking Breast AI solution. Designed to improve the accuracy and efficiency of early breast cancer detection, our AI-driven tool offers an 8% improvement in sensitivity and a 7% reduction in the rate of recalls. By reducing reading time by up to 52.7%, our Breast AI solution enables radiologists to get fast results to oncologists to provide better care for their patients while optimizing their workflow. 

Our Breast AI technology aligns with BI-RADS breast tissue density categories, ensuring consistent, standardized, and accurate results. Moreover, Arterys Breast AI can be accessed anytime, anywhere, with an internet connection and seamlessly integrates with existing PACS, EHR, worklist, notification, and dictation systems.

 

Join Us at Booth #408

We invite you to visit us at Booth #408 during the 2023 SBI Breast Imaging Symposium to discover how Arterys Breast AI can revolutionize your breast cancer detection practice. Our team, including Peter Graham, Head of Commercialization, and Tim Costeiu, Sr. Director of Sales, will be available to answer your questions and demonstrate the power of our AI solution.

The 2023 SBI Breast Imaging Symposium promises to be an enriching experience for all attendees, providing valuable insights and networking opportunities. Be sure to visit Arterys at Booth #408 to explore our transformative Breast AI solution and learn how it can help you advance the care of your patients and enhance your practice. We look forward to seeing you in May 2023!

Book a Demo at SBI 2023

Arterys And Therapixel Team Up For AI-powered Breast Cancer Solution

Arterys And Therapixel Team Up For AI-powered Breast Cancer Solution

Arterys, a Tempus company, has announced a US and EU distribution agreement with Therapixel, a medical imaging software company providing AI...

Read More
Arterys' Breast AI Suite: Transforming Breast Screening & Cancer Detection at SBI 2023

Arterys' Breast AI Suite: Transforming Breast Screening & Cancer Detection at SBI 2023

The 2023 Society of Breast Imaging (SBI) Breast Imaging Symposium is a must-attend event for radiologists and healthcare professionals involved in...

Read More
March Events: Procedural And Artificial Intelligence Developments In Oncology And Radiology

March Events: Procedural And Artificial Intelligence Developments In Oncology And Radiology

There are a lot of radiology conferences and events in March, and you can connect with the Arterys team at a number of them! Six specific events in...

Read More
Arterys has joined Tempus, and we are excited to reintroduce ourselves to you as Tempus Radiology.
Tempus is a leading technology company that is advancing precision medicine through the practical application of data and artificial intelligence in healthcare. By joining forces, Arterys’ product will be integrated into Tempus’ solutions, enabling providers to access a comprehensive patient view (now inclusive of radiology scans) and researchers to leverage this new data modality to optimize the drug development process.